SEC CRD #802-77204
--> BioStar Capital - Visionary Healthcare Investors | United States top of page INVESTOR PORTAL VALUE-ADD INVESTOR IN TRANSFORMATIONAL MEDICAL TECHNOLOGIES The BioStar Capital Advantage Our unique strategy has con sistently produced life-changing outcomes for patients an d rewarding return s for investors. Learn More Business Acumen Meets Clinical Expertise Representing a unique collaboration of renowned healthcare clinicians and executive s, medical thoug ht leaders, and financial professionals. Meet Our Team Portfolio Milestone: AVS Acquired by Stryker Read the Official Announcement Amplitude Vascular Systems (AVS), developer of the Pulse IVL platform and a BioStar Capital portfolio company, has been acquired by Stryker. Innovations with an Impact We have been at the forefront of transformational medical technology and investment opportunities for over two decades. View Our Portfolio News May 19, 2026 BioStar Capital-Backed Amplitude Vascular Systems $835M Acquisition by Stryker Reflects Strength of Michigan s Medtech Ecosystem See More Of Our Latest News bottom of page --> About top of page INVESTOR PORTAL ABOUT Founded in 2005 by a nationally recognized leader in cardiology, Dr. Louis A. Cannon, we are a uniquely structured venture capital firm focused on transformative medical technologies. Our team composition includes renowned healthcare clinicians and executives, medical thought leaders and financial professionals, differentiating us within the industry and mitigatin
LOUIS CANNON
FOUNDER AND SENIOR MANAGING DIRECTOR
📞 (231) 838-4175
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$835M–$835M
Location
CHARLEVOIX, MI
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.